Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
1p31p32 microdeletion syndrome is a rare chromosomal anomaly syndrome, resulting from the partial deletion of the short arm of chromosome 1, characterized by developmental delay, corpus callosum agenesis/hypoplasia and craniofacial dysmorphism, such as macrocephaly (caused by hydrocephalus or ventriculomegaly), low-set ears, anteverted nostrils and micrognathia. Urinary tract defects (e.g. vesicoureteral reflux, urinary incontinence) are also frequently associated. Other reported variable manifestations include hypotonia, tethered spinal cord, Chiari type I malformation and seizures.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for chromosome 1p32-p31 deletion syndrome.
1 publication has been identified in PubMed for chromosome 1p32-p31 deletion syndrome. Research spans Case Report / Case Series (100%).
Nhongo SS (2025). [PMID: 40606574](https://pubmed.ncbi.nlm.nih.gov/40606574/). *JPRAS Open*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about chromosome 1p32-p31 deletion syndrome